Business Update

Chiron CEO says he is unclear when flu vaccine sales can resume

Published in Health and Medicine Week, January 31st, 2005

Chiron Corp. Chairman and Chief Executive said there is "no basis yet to predict whether or when" the company will be able to get back to production of flu vaccine for the United States.

British health regulators on October 5 revoked the Emeryville, California-based company's manufacturing license for its Liverpool facility, which was meant to provide half of the United States' flu shots this winter.

Last month, British regulators extended the halt on production at the plant until the beginning of April, calling Chiron manufacturing for next flu season into question.

Speaking January 12, 2005, at the J.P. Morgan Healthcare...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2005-01-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry